ConductScience.org, home

Gene · 64772

ENGASE: endo-beta-N-acetylglucosaminidase

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ENGASE: endo-beta-N-acetylglucosaminidase. Genes, record 64772. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/64772

On this page

Gene

Symbol
ENGASE
HGNC
Name
endo-beta-N-acetylglucosaminidase
HGNC
NCBI Gene ID
64772
NCBI Gene
HGNC ID
HGNC:24622
HGNC
Ensembl
ENSG00000167280
NCBI Gene
Aliases
FLJ21865
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q8NFI3Cytosolic endo-beta-N-acetylglucosaminidase7430Ensembl, GeneID, HGNC

Source UniProt

Patents18

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-1917438Q8NFI3Espacenet
JP 2025517970 A2025-06-1217438Q8NFI3Espacenet
US 11564998 B22023-01-318973Q8NFI3Espacenet
US 11564998 B22023-01-319170Q8NFI3Espacenet
US 11446398 B22022-09-2027221Q8NFI3Espacenet
JP 2022524081 A2022-04-27130192Q8NFI3Espacenet
US 11078247 B22021-08-033555Q8NFI3Espacenet
WO 2020043864 A12020-03-05795Q8NFI3Espacenet
US 10463751 B22019-11-058973Q8NFI3Espacenet
US 10463751 B22019-11-059170Q8NFI3Espacenet

1 to 10 of 18

See all 18 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants731

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleENGASE papersNewest fiscal year
R01AI149297Engineering IgG-specific endoglycosidases to selectively defeat effector functions52025
P30CA014195Cancer Center Support Grant (CCSG)42025
P30CA013330Cancer Center Support Grant32025
T32HL007088Pre-and Postgraduate Training in Molecular Hematology32025
P30CA014051Cancer Center Support (Core) Grant22025
P30CA021765Cancer Center Support Grant (CCSG)22025
P30CA068485Cancer Center Support Grant22025
P30EY008126Core Grant in Vision Research22025
T32AI095190Signaling Pathways in Innate Immunity22025
P01HL131474Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis12025

1 to 10 of 731Source NIH's project files

See all 731 nih grants

Papers1,359

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Circulating cell type senescence signatures track distinct dimensions of health status and trajectories in human longitudinal cohorts.Cell Rep202642276069PubTator, text miningPubMed
Glycan pairing in therapeutic IgG orchestrates Fcγ receptor engagement and ADCC: an integrated structure-function approach for thorough evaluation of Fc N-glycans as critical quality attributes.MAbs202641925250PubTator, text miningPubMed
Site-Specific Glycan Conjugation Improves Stability and Efficacy of an Antibody-Drug Conjugates Bearing DXd as a Cytotoxic Payload.ACS Omega202641799094PubTator, text miningPubMed
Crystal structure of endo-β-N-acetylglucosaminidase HSα.Acta Crystallogr F Struct Biol Commun202641784007PubTator, text miningPubMed
CT Radiogenomics Provides a Novel Factor for cM0(i+) Risk Stratification in Localized Renal Cell Carcinoma: A Model Linked to a Circulating Tumor Cell-Related Gene Signature.Acad Radiol202641765704PubTator, text miningPubMed
Group A Streptococcal Virulence Factors and Vaccine Development-An Update.Microorganisms202641753644PubTator, text miningPubMed
Circulating Cell Type Senescence Signatures Reveal High-Resolution Health Status and Trajectories in Human Longitudinal Studies.medRxiv202641728302PubTator, text miningPubMed
Simultaneous detection of PNGase and ENGase activities in tissue lysate or cytosol using a simply designed high-mannose-type glycopeptide probe containing an Asn-leu-leu sequence.Bioorg Med Chem Lett202641687896PubTator, text miningPubMed
Identification of potential therapeutic targets for stroke and its subtypes by integrating proteomes and genetics from human plasma.Brain Commun202641488603PubTator, text miningPubMed
Deciphering the molecular basis of skin color variation through transcriptomics and machine learning.Sci Rep202541419520PubTator, text miningPubMed

1 to 10 of 1,359

See all 1,359 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/64772

GET https://conductscience.org/api/genes/v1/64772/patents